Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #38589 on Relief Therapeutics Holding AG (RLFTF)
elllk
04/19/21 3:49 PM
#38593 RE: Ria2 #38589
ACER-001 is a proprietary powder formulation of sodium phenylbutyrate (NaPB). The formulation is designed to be both taste-masked and immediate release. ACER-001 is being developed using a microencapsulation process for the treatment of various inborn errors of metabolism, including UCDs and MSUD. ACER-001 microparticles consist of a core center, a layer of active drug, and a taste-masking coating that quickly dissolves in the stomach, to avoid a bitter taste while still allowing for rapid systemic release.